Request Sample Inquiry
Cancer Pain Market

Cancer Pain Market

Cancer Pain Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

195

Base Year:

2023

Date

Jun - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2505

Segments Covered
  • By Drug Type By Drug Type Opioids, Non-Opioids, Nerve Blockers
  • By Disease Indication By Disease Indication Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Other Disease Indications
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 7.39 Billion
Revenue 2032Revenue 2032: USD 11.86 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 5.4%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Cancer Pain Market - Segment Analysis
    1. Overview
    2. Global Cancer Pain Market, 2016 - 2028 (USD Million)
    3. Global Cancer Pain Market - by Drug Type
      1. By Opioids
      2. By Non-Opioids
      3. By Nerve Blockers
    4. Global Cancer Pain Market - by Disease Indication
      1. By Lung Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Prostate Cancer
      5. By Blood Cancer
      6. By Other Disease Indications
    5. Global Cancer Pain Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Cancer Pain Market - Segment Analysis
    1. Overview
    2. North America Cancer Pain Market, 2016 - 2028 (USD Million)
    3. North America Cancer Pain Market, by Drug Type
      1. By Opioids
      2. By Non-Opioids
      3. By Nerve Blockers
    4. North America Cancer Pain Market, by Disease Indication
      1. By Lung Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Prostate Cancer
      5. By Blood Cancer
      6. By Other Disease Indications
    5. North America Cancer Pain Market, by Country
      1. U.S.
        1. U.S. Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. U.S. Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      2. Canada
        1. Canada Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Canada Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      3. Mexico
        1. Mexico Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Mexico Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
  5. Europe Cancer Pain Market - Segment Analysis
    1. Overview
    2. Europe Cancer Pain Market, 2016 - 2028 (USD Million)
    3. Europe Cancer Pain Market, by Drug Type
      1. By Opioids
      2. By Non-Opioids
      3. By Nerve Blockers
    4. Europe Cancer Pain Market, by Disease Indication
      1. By Lung Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Prostate Cancer
      5. By Blood Cancer
      6. By Other Disease Indications
    5. Europe Cancer Pain Market, by Country
      1. Germany
        1. Germany Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Germany Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      2. UK
        1. UK Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. UK Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      3. France
        1. France Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. France Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      4. Spain
        1. Spain Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Spain Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      5. Italy
        1. Italy Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Italy Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      6. BENELUX
        1. BENELUX Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. BENELUX Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      7. Rest of Europe
        1. Rest Of Europe Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Rest Of Europe Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
  6. Asia Pacific Cancer Pain Market - Segment Analysis
    1. Overview
    2. Asia Pacific Cancer Pain Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Cancer Pain Market, by Drug Type
      1. By Opioids
      2. By Non-Opioids
      3. By Nerve Blockers
    4. Asia Pacific Cancer Pain Market, by Disease Indication
      1. By Lung Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Prostate Cancer
      5. By Blood Cancer
      6. By Other Disease Indications
    5. Asia Pacific Cancer Pain Market, by Country
      1. China
        1. China Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. China Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      2. Japan
        1. Japan Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Japan Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      3. India
        1. India Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. India Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      4. South Korea
        1. South Korea Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. South Korea Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      5. South East Asia
        1. South East Asia Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. South East Asia Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Rest of Asia Pacific Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
  7. Latin America Cancer Pain Market - Segment Analysis
    1. Overview
    2. Latin America Cancer Pain Market, 2016 - 2028 (USD Million)
    3. Latin America Cancer Pain Market, by Drug Type
      1. By Opioids
      2. By Non-Opioids
      3. By Nerve Blockers
    4. Latin America Cancer Pain Market, by Disease Indication
      1. By Lung Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Prostate Cancer
      5. By Blood Cancer
      6. By Other Disease Indications
    5. Latin America Cancer Pain Market, by Country
      1. Brazil
        1. Brazil Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Brazil Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      2. Argentina
        1. Argentina Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Argentina Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      3. Rest of Latin America
        1. Rest of Latin America Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Rest of Latin America Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
  8. Middle East & Africa Cancer Pain Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Cancer Pain Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Cancer Pain Market, by Drug Type
      1. By Opioids
      2. By Non-Opioids
      3. By Nerve Blockers
    4. Middle East & Africa Cancer Pain Market, by Disease Indication
      1. By Lung Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Prostate Cancer
      5. By Blood Cancer
      6. By Other Disease Indications
    5. Middle East & Africa Cancer Pain Market, by Country
      1. GCC Countries
        1. GCC Countries Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. GCC Countries Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      2. South Africa
        1. South Africa Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. South Africa Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Cancer Pain Market, By Drug Type
          1. By Opioids
          2. By Non-Opioids
          3. By Nerve Blockers
        2. Rest of Middle East & Africa Cancer Pain Market, By Disease Indication
          1. By Lung Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Prostate Cancer
          5. By Blood Cancer
          6. By Other Disease Indications
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Teva Pharmaceutical Industries Ltd. (Israel)
    2. Orexo AB (Sweden)
    3. Aoxing Pharmaceutical Company Inc. (U.S.)
    4. Grünenthal Pharma GmbH & Co. KG (Germany)
    5. BioDelivery Sciences International Inc. (U.S.)
    6. Daiichi Sankyo Co. Ltd. (Japan)
    7. CK Life Sciences (Wex Pharmaceuticals) (Hong Kong)
    8. Mundipharma International Ltd. (UK)
    9. Hisamitsu Pharmaceutical Co.Inc. (Japan)
    10. Pfizer Inc. (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 25-Jun-2024
FDA Advances Cancer Treatment with Approvals and Fast Track Designations
FAQ
Frequently Asked Question

  • The global Cancer Pain valued at USD 7.39 Billion in 2023 and is expected to reach USD 11.86 Billion in 2032 growing at a CAGR of 5.4%.

  • The prominent players in the market are Teva Pharmaceutical Industries Ltd. (Israel), Orexo AB (Sweden), Aoxing Pharmaceutical Company Inc. (U.S.), Grünenthal Pharma GmbH & Co. KG (Germany), BioDelivery Sciences International Inc. (U.S.), Daiichi Sankyo Co. Ltd. (Japan), CK Life Sciences (Wex Pharmaceuticals) (Hong Kong), Mundipharma International Ltd. (UK), Hisamitsu Pharmaceutical Co.Inc. (Japan), Pfizer Inc. (U.S.).

  • The market is project to grow at a CAGR of 5.4% between 2024 and 2032.

  • The driving factors of the Cancer Pain include

  • North America was the leading regional segment of the Cancer Pain in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy